Andrew James Jensen

Title: The Innovations of Andrew James Jensen

Introduction

Andrew James Jensen is a notable inventor based in Ledyard, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on the development of novel crystalline forms and solid compositions that have therapeutic applications.

Latest Patents

One of Jensen's latest patents is titled "Crystalline forms of 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]cyclobutaneacetonitrile, and use thereof." This invention discloses novel crystalline forms, including Form 1 anhydrous free base and Form 2 monohydrate, along with pharmaceutical compositions containing them. Another significant patent is for "Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole." This invention relates to solid forms of the compound and methods for their preparation, as well as their therapeutic or prophylactic uses.

Career Highlights

Andrew James Jensen is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative pharmaceutical solutions that address various health challenges.

Collaborations

Throughout his career, Jensen has collaborated with notable colleagues, including Suman Luthra and Paul Francis Richardson. These collaborations have further enhanced the impact of his inventions in the pharmaceutical industry.

Conclusion

Andrew James Jensen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective therapeutic solutions.